NCT05084495View on ClinicalTrials.gov

The Use of Flecainide for Treatment of Atrial Fibrillation

CompletedOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

February 1, 2022

Primary Completion Date

April 15, 2025

Study Completion Date

April 15, 2025

Conditions
Atrial Fibrillation
Interventions
DIAGNOSTIC_TEST

Global peak atrial longitudinal strain and ECG

During the follow-up period the patient will have four clinical visits, during which clinical data, advanced echocardiographic data (strain and speckle tracking) and ECGs (Glasgow criteria) will be collected

Trial Locations (1)

25187

Clinical Sciences, Helsingborg Medical Faculty Lund University, Helsingborg

All Listed Sponsors
lead

Lund University

OTHER